Skip to main content

Table 1 Summary of subjects demographic characteristics

From: Safety, tolerability, pharmacokinetics and pharmacodynamics of GSK2239633, a CC-chemokine receptor 4 antagonist, in healthy male subjects: results from an open-label and from a randomised study

Demographics Microdose intravenous study (n = 6) Single oral dose study (n = 24)
Age, years; Mean [range] 22.7 [20.0–26.0] 37.2 [20.0–65.0]
  Sex; n (%)   
  Male 6 (100%) 24 (100%)
Height, cm; Mean [range] 180.0 [172.0–187.0] 180.5 [163.0–197.0])
Weight, kg; Mean [range] 71.8 [60.1–85.5] 81.0 [65.7–106.0]
Body mass index, kg/m2; Mean [range] 22.1 [19.3–24.6] 24.9 [19.8–29.1]
Ethnicity; n (%)   
  Hispanic or Latino 0 1 (4%)
  Not Hispanic or Latino 6 (100%) 23 (96%)
Race; n (%)a   
  White-White/Caucasian/European heritage 6 (100%) 20 (83%)
  White-Arabic/North African heritage 0 1 (4%)
  Asian-Central/South Asian heritage 0 1 (4%)
  Asian-South East Asian heritage 0 2 (8%)